
Andrés Lozano
Andrés Lozano is a renowned neurosurgeon and researcher at the University of Toronto, originally from Sevilla, Spain. With a career spanning several decades, he has made significant contributions to the field of neurology, particularly in the treatment of Parkinson's disease. Lozano is a key figure in innovative therapies, including stem cell transplants aimed at alleviating symptoms of neurodegenerative disorders. His recent involvement in a clinical trial has garnered attention for demonstrating the potential effectiveness of these transplants in reducing involuntary movements in Parkinson's patients, marking a promising advancement in treatment options.
Not in the pool (under ¢1).
Recent news mentions
Dr. Andres Lozano led the surgical team that implanted Neuralink chips in two Canadian patients.
Brain chips from Musk’s Neuralink implanted in two Canadian men with spinal cord injuriesAndrés Lozano is one of the authors of the American trial and emphasizes that this treatment is not a cure for Parkinson's disease.
Éxito inicial de dos trasplantes de células madre contra el párkinson | Ciencia



